Breakout Discussion Groups Announced at CHI's Clinical Protocol Optimization Conference

Aug. 30, 2011 - PRLog -- Cambridge Healthtech Institute (CHI) and Barnett International today announced details for ten concurrent breakout discussion groups that will be hosted by a facilitator(s) at its Inaugural Clinical Protocol Optimization conference. This confererence is set for October 3-4, 2011 at the Boston Marriott Cambridge in Cambridge, MA.  To get the most out of this interactive format, delegates will bring examples of their work to engage in active problem solving and get new ideas surrounding the protocol.

The following concurrent breakout discussion groups will be held on day one of the event between 4:00-5:00 pm:

Strategies for Clearly Defining and Managing the Protocol Development Process
Nariman Nasser, Director, Participant Recruitment Service Clinical and Translational Science Institute, University of California, San Francisco

Lessons Learned from Protocol Amendments and Understanding What Makes a Protocol Unexecutable
Moderator:  Beth Harper, Chief Clinical Officer, Centerphase Solutions, Inc.

Identifying Key Stakeholders, Integrating Feedback and Monitoring Change Throughout the Research Process
Co-Moderator: Laurie Lebo, Ph.D., CCRP, PMP, Research Services, Vanderbilt University Medical Center
Co-Moderator:  Paul Hoskins, Head, Clinical Operations and Preclinical Outsourcing, Galleon Pharmaceuticals

How to Manage the Protocol Development Process with Outsourced Writing Resources
Moderator: Cheryl Vitow, Consultant Medical Writer and Clinical Science Manager, Clinical and Medical Affairs, Ortho Clinical Diagnostics

Complementing Process Improvements with Technology for Protocol Design
Co-Moderators: Suzanne Collins, Director, Operations, Trifecta Multimedical
Co-Moderators: Penny Carlson, Global Clinical Program Manager, Consultant, Genzyme, Inc.

Strategies for Proactive Issues Management and Resolution Strategies for the CRA
Moderator: Kristopher Chrisman, CCRP, Senior CRA, Metabolism & Diabetes/Internal Medicine, US Clinical Research, sanofi-aventis

Effective Study Site Evaluation Plan Development and Implementation
Moderator: Christopher Beardmore, President and CEO, Oncology, Translational Research Management, LLC

New Recruitment Tools are Available, Yet are They Providing Results for the Site and Industry?
Moderator: Joan Chambers, COO, CenterWatch

Site Relationship Management:  Selecting the Right Sites for Your Study
Moderator: Chris Hoyle, M.B.A., Executive Director, Elite Research Network

Those that register by September 2 will save up to $200.

To register and view the full agenda, visit http://www.BarnettClinicalSummit.com/ProtocolOptimization

To inquire about sponsorship/exhibit opportunities, contact Ilana Quigley at 781-972-5431, iquigley@healthtech.com.

Writers and editors are invited to attend.  To request a press pass email tfielding@healthtech.com.

About Cambridge Healthtech Institute (www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

About Barnett International (www.barnettinternational.com)

Founded in 1979, Barnett International is widely recognized for its superior consulting services and its targeted education and training programs. Barnett helps clients get the most out of their research and development dollars by managing change effectively, improving organizational performance, and enhancing staff knowledge. The Barnett approach is a unique combination of strategy development and practical, hands-on implementation. The "Barnett Difference" is evident in our deep understanding of the clinical research process and in the rapid and tangible performance improvements we deliver.

We help pharmaceutical, biotechnology and medical device companies maximize the speed and quality of their product development efforts. With an international presence and many staff members working from the client site for increased benefits, Barnett is able to apply a global expertise to its projects. Our services include educational programs and products as well as consulting services.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com